Home / News / Global Direct-to-Consumer Genetic Testing Market to Reach Worth USD 340 Mn by 2022 – Credence Research

Global Direct-to-Consumer Genetic Testing Market to Reach Worth USD 340 Mn by 2022 – Credence Research

According to the latest report published by Credence Research, Inc. “Direct-to-Consumer Genetic Testing Market Growth, Future Prospects and Competitive Analysis, 2016-2022,” the direct-to-consumer genetic testing market was valued at USD 70.2 Mn in 2015, and is expected to reach USD 340 Mn by 2022, expanding at a CAGR of 25.1% from 2016 to 2022.

Market Insights

Conventionally, genetic tests have been made available only through healthcare providers at recommendations from physicians . Direct-to-consumer (DTC) genetic testing is defined as genetic teats marketed directly to individuals through agencies such as internet, pharmacies and others. DTC genetic testing market is predominantly driven by growing awareness in public about genetic diseases, growing tendency to take proactive role in personal healthcare and the ongoing trend of understanding ancestral origins.

Browse the full report Direct-to-Consumer Genetic Testing: Market Growth, Future Prospects and Competitive Analysis, 2016-2022 report at http://www.credenceresearch.com/report/direct-to-consumer-genetic-testing-market

Since 2010, the prices of genome testing solutions have observed a sharp decline in prices and the market is mostly concentrated in the hands of a few market players. The utilization of genomic data is yet not perfected, however increasing researches and growing availability of these solutions will pave way for further improvements in the business dynamics. On the other hand, notable risks such as vulnerability to misleading outcomes from unproven or invalid diagnosis, taking improper precautions or health decisions sans involvement of physician assistance and the associated repercussions may hold back the pace of this market. Another challenge to the market growth is potential risk of invasion of genetic privacy through unauthorized use of consumer data.

Genetic data services are roughly categorized into two sections namely, genome reading and interpretation of genomic data. The current market players mostly offer services that club the two categories into a single product. However some players have a differentiated their portfolio by offering DNA genotype as an individual product. Companies offering DTC genetic tests have varied portfolio and have varied revenue sources.

Browse the full report at http://www.credenceresearch.com/report/direct-to-consumer-genetic-testing-market

The global DTC genetic testing market is highly concentrated, with a handful of companies offering testing solutions. Some of the major players offering direct-to-consumer genetic testing solutions are 23andMe, MD Revolution, GeneByGene, DNA DTC, Genetrainer, Myriad Genetics, Genecodebook Oy and others.

Latest Reports:

Angina Pectoris Treatment Market By Drug Type (Antiplatelet agents, Beta-adrenergic blocking agents, Calcium channel blockers, Short & Long – acting Nitroglycerines, Angiotensin-converting enzyme inhibitors, Anti-ischemic agents) – Growth, Share, Opportunities & Competitive Analysis, 2015 – 2022

Drug Delivery Technologies Market By Application (Oral, Pulmonary, Transdermal, Injectable, Nasal, Implantable & Others) – Growth, Share, Opportunities & Competitive Analysis, 2015 – 2022

Alzheimer’s Therapeutic Market By Drug Type (Memantine Hydrochloride, Donepezil Hydrochloride, Rivastigmine, Galantamine Hydrobromide) – Growth, Share, Opportunities & Competitive Analysis, 2015 – 2022

About Us:

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Who we are

Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.

Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.

Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.

What we do

We serve customers at each level of their organization, in whatever limit we can be most helpful, whether as a trusted counsel to top management or as a hands-on mentor for forefront representatives. For each engagement, we collect a group with the most suitable experience and ability.

No matter the challenge, we concentrate on delivering functional and persevering results, and preparing our customers to develop and lead. We join forces with customers to place suggestions into practice. Our research specialist work straightforwardly with customers over long stretches to create workforce aptitudes, drive operational change, and apply new working strategies.


Name: Chris Smith

Designation: Global Sales Manager

E-mail: sales@credenceresearch.com

Ph: 1-800-361-8290

Web:  Credence Research


Release ID: 3682

About Chris Smith

Check Also


Global Solar Lamp Market Size, Share, Trends, Growth and Forecast 2016 – Acute Market Reports

The China Solar Lamp Industry 2016 Market Research Report is a professional and in-depth study ...